Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.8 USD
8.57%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Accrued Liabilities
|
Adaptive Biotechnologies Corp
Accrued Liabilities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Accrued Liabilities
$23.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accrued Liabilities
$4.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Accrued Liabilities
$2.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accrued Liabilities
$319.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Accrued Liabilities
$607m
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Adaptive Biotechnologies Corp's Accrued Liabilities?
Accrued Liabilities
23.9m
USD
23.9m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Accrued Liabilities amounts to 23.9m USD.
What is Adaptive Biotechnologies Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
29%
29%
Over the last year, the Accrued Liabilities growth was 2%. The average annual Accrued Liabilities growth rates for Adaptive Biotechnologies Corp have been 1% over the past three years , 29% over the past five years .
You don't have any saved screeners yet
